State-of-the-art infrastructure and enabling technologies at Jubilant R&D centres further augment our philosophy of creative partnering and provides all collaborators optimal outcome in managing their functional and portfolio needs.
The state-of-the-art technology platforms span across synthetic organic chemistry, medicinal chemistry, scale up chemistry, Computational Chemistry and parallel synthesis.
